Shares of ValiRx Plc (LON:VAL) shot up 0% during mid-day trading on Thursday . The stock traded as high as GBX 3.67 ($0.05) and last traded at GBX 3.50 ($0.05). 5,390,728 shares changed hands during trading, an increase of 45% from the average session volume of 3,720,000 shares. The stock had previously closed at GBX 3.50 ($0.05).
Separately, Beaufort Securities restated a “speculative buy” rating on shares of ValiRx in a research report on Friday, January 12th.
The firm has a market cap of $11.83 and a PE ratio of -58.33.
ValiRx Company Profile
ValiRx plc is a biopharmaceutical company. The principal activity of the Company is the development of oncology therapeutics and companion diagnostics. It focuses on the treatment of cancer and associated biomarkers, specializing in epigenomic and genetic analysis. It operates in two business segments: drug development and the sale of self-test drug kits.
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.